# A Real-world Study to Learn About of the Characteristics and Outcomes of Advanced or Metastatic Bladder Cancer Patients With Different Histologies

> **NCT07897669** · — · NOT_YET_RECRUITING · sponsor: **Pfizer** · enrollment: 5122 (estimated)

## Conditions studied

- Metastatic Urothelial Carcinoma
- Urothelial Cancer
- Urothelial Carcinoma
- Locally Advanced or Metastatic Urothelial Carcinoma
- Bladder Cancer
- Bladder Neoplasms
- Bladder Tumors
- Cancer of Bladder
- Cancer of the Bladder
- Malignant Tumor of Urinary Bladder
- Neoplasms, Bladder
- Urinary Bladder Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07897669
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-10-21
- **Primary completion:** 2027-04-01
- **Final completion:** 2027-04-01
- **Target enrollment:** 5122 (ESTIMATED)
- **Last updated:** 2026-10-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07897669

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07897669, "A Real-world Study to Learn About of the Characteristics and Outcomes of Advanced or Metastatic Bladder Cancer Patients With Different Histologies". Retrieved via MORVS 2026-11-22 from https://api.morvs.ai/clinical/NCT07897669. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
